Location | Cecal | Distal colonic pellets | |||||||
---|---|---|---|---|---|---|---|---|---|
Sex | Female | Male | Female | Male | |||||
Condition | Control | GS | Control | GS | Control | GS | Control | GS | |
SCFA | Total (µmol/gww)* | 41.1 ± 4.3 | 50.2 ± 6.5 | 53.2 ± 6.6 | 34.6a ± 4.7 | 32.3 ± 5.4 | 25.6 ± 2.9 | 35 ± 3.9 | 27 ± 5.2 |
Acetate (%) | 58.6 ± 2.1% | 64.0 ± 2.3% | 62.2 ± 1.9% | 55.1 ± 3% | 60 ± 2.3% | 63.4b ± 1.3% | 62 ± 1.7% | 56.8b ± 4% | |
Propionate (%) | 15.6 ± 0.5% | 15.3b ± 0.4% | 16.2 ± 0.8% | 17.9b ± 0.5% | 11.9 ± 0.6% | 12.5 ± 1.1% | 12.4 ± 1.1% | 13.7 ± 1% | |
Butyrate (%) | 20.0 ± 1% | 15.6 ± 1% | 15.0 ± 0.6% | 17.6 ± 2% | 21.1 ± 2.1% | 16.1 ± 1% | 17.2 ± 1.3% | 18.6 ± 3.2% | |
BCFA | Total (µmol/gww)* | 1.3 ± 0.1 | 1.1b ± 0.1 | 1.9 ± 0.2 | 1.9b ± 0.1 | 1.4 ± 0.1 | 1.3 ± 0.1 | 1.7 ± 0.1 | 1.7 ± 0.2% |
Iso-butyric (%) | 1.8 ± 0.1% | 1.6b ± 0.2% | 2.0 ± 0.2% | 3.0b ± 0.3% | 2.1 ± 0.2% | 2.3 ± 0.3% | 2.3 ± 0.2% | 3 ± 0.5% | |
Iso-valeric (%) | 1.6 ± 0.1% | 1.4b ± 0.2% | 2.0 ± 0.4% | 3.1b ± 0.4 | 2.7 ± 0.4% | 2.9 ± 0.4% | 2.7 ± 0.3% | 4.5 ± 0.9% | |
Valeric(%) | 2.3 ± 0.1% | 2.2b ± 0.2% | 2.3 ± 0.2% | 3.2b ± 0.4% | 1.8 ± 0.1% | 2 ± 0.2% | 1.7 ± 0.2% | 2.2 ± 0.3 |